Suchergebnisse - "Wan, Xiaofeng"

PubPharm (40)

1

Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11

enthalten in: Journal of experimental & clinical cancer research : CR | 2024

von Wang, Z. | Zong, H. | Liu, W. | +13

2

Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11

enthalten in: Journal of experimental & clinical cancer research | 2024

von Wang, Z. | Zong, H. | Liu, W. | +13

3

The chemokine CCL20 can assist AFP in serological diagnosis of hepatocellular carcinoma

enthalten in: Heliyon | 2024

von Deng, Q. | Zhang, X. | Wan, X. | +5

4

Application of miR-3919, polynucleotide derivative thereof or agonist thereof

enthalten in: Europäisches Patentamt | 2024

von ZHANG FANGXI | LI RUNSHENG | SHEN MING | +2

5

Sulforaphane inhibits the growth of prostate cancer by regulating the microRNA-3919/DJ-1 axis

enthalten in: Frontiers in oncology | 2024

von Zhang, F. | Wan, X. | Zhan, J. | +2

6

Structural Characterization and Anti-Osteoporosis Effects of a Novel Sialoglycopeptide from Tuna Eggs

enthalten in: Marine drugs | 2023

von Hu, S. | Wan, X. | Zhu, H. | +1

7

Effects of obstetric critical care simulation training on core competency and learning experience of midwives : A pilot quasi-experimental study

enthalten in: Nurse education in practice | 2023

von Zou, Y. | Zhai, J. | Wang, X. | +6

8

Structural Characterization and Effects on Insulin Resistance of a Novel Chondroitin Sulfate from Halaelurus burgeri Skin

enthalten in: Marine drugs | 2023

von Hu, S. | Zhu, H. | Chen, S. | +4

9

Pan-cancer analysis reveals the associations between MMP13 high expression and carcinogenesis and its value as a serum diagnostic marker

enthalten in: Aging | 2023

von Zhang, X. | Deng, Q. | Wan, X. | +5

10

Compound for improving secretion level of testosterone and application thereof

enthalten in: Europäisches Patentamt | 2023

von LI RUNSHENG | ZHANG LINGLING | XU DEFENG | +5